| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acting Chief Financial Officer
1 company
Reardon Tighe is an Acting Chief Financial Officer at Janux Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $9.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | JANX Janux Therapeutics, Inc. | Acting Chief Financial Officer | Sell | 822,721 | $54.75 | $45,043,974.75 | -17.2% | -18.1% | -53.7% | |
| Nov 13, 2023 | JANX Janux Therapeutics, Inc. | Acting Chief Financial Officer | Buy | 849,854 | $5.87 | $4,988,642.98 | New | +21.4% | +645.3% | |
| Jun 15, 2021 | JANX Janux Therapeutics, Inc. | Acting Chief Financial Officer | Buy | 629,411 | $17.00 | $10,699,987.00 | +16.3% | +52.6% | -37.6% |